Stocks and Investing Stocks and Investing
Tue, December 8, 2020
[ 12:00 AM ] - WOPRAI
Suneet Kamath Maintained (ALL) at Strong Buy with Decreased Target to $125 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Richard Close Initiated (ACCD) at Strong Buy and Held Target at $59 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Suneet Kamath Upgraded (CB) to Strong Buy and Increased Target to $176 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Chris Carey Initiated (SPB) at Buy and Held Target at $80 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Alex Kurtz Maintained (SMAR) at Buy with Increased Target to $82 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Scott Berg Maintained (SMAR) at Strong Buy with Increased Target to $80 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (SMAR) at Buy with Increased Target to $90 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (SMAR) at Strong Buy with Increased Target to $85 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Matthew Sheerin Downgraded (SNX) to Hold and Decreased Target to $85 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Kevin Barker Initiated (AGNC) at Buy and Held Target at $17 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Raj Ray Upgraded (AU) to Buy and Held Target at $36 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ATRA) at Strong Buy with Increased Target to $775 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Chris Carey Initiated (TAP) at Hold and Held Target at $51 on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Nigel Coe Upgraded (TT) to Hold on, Dec 8th, 2020
[ 12:00 AM ] - WOPRAI
Brian Vaccaro Maintained (TXRH) at Strong Buy with Increased Target to $90 on, Dec 8th, 2020
Mon, December 7, 2020
[ 12:00 AM ] - WOPRAI
Myles Walton Upgraded (BA) to Strong Buy and Increased Target to $300 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (WBS) at Hold with Increased Target to $42 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
William Wallace Maintained (WBS) at Strong Buy with Increased Target to $50 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Allison Landry Maintained (XPO) at Buy with Increased Target to $140 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Edward Yruma Maintained (WWW) at Buy with Increased Target to $37 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Armintas Sinkevicius Maintained (AN) at Sell with Increased Target to $56 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Scott Schoenhaus Downgraded (TDOC) to Hold on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Craig Hettenbach Maintained (AVGO) at Buy with Increased Target to $44 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Nicolas Cote-Colisson Downgraded (ATUS) to Hold and Held Target at $34 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Philip Gibbs Maintained (ATI) at Buy with Increased Target to $25 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (BOKF) at Hold with Increased Target to $81 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (ZION) at Hold with Increased Target to $47 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
John Pancari Upgraded (ZION) to Buy on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (SNV) at Buy with Increased Target to $40 on, Dec 7th, 2020
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (SNDX) at Hold with Increased Target to $25 on, Dec 7th, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $25 on, Dec 7th, 2020


Published on 2024-10-27 14:56:43 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $17 to $25 on, Dec 7th, 2020.

David has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Konstantinos Aprilakis of "Stifel" Initiated at Strong Buy and Held Target at $32 on, Thursday, December 3rd, 2020
Contributing Sources